PARP inhibitor-related acute renal failure: a real-world study based on the FDA adverse event reporting system database-Reference-Cited by-同舟云学术

PARP inhibitor-related acute renal failure: a real-world study based on the FDA adverse event reporting system database

Published:2024-07-08 Issue: Volume: Page:1-9
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Ren Xiayang¹^ORCID,Sun Ping²,Wang Yanfeng³

Affiliation:

1. Department of Pharmacy, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2. Department of Cancer Prevention, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

3. Department of Comprehensive Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Funder

Special Research Fund for Central Universities, Peking Union Medical College

the program of Beijing Hope Run Special Fund of Cancer Foundation of China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2024.2376690

Reference56 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. PARP inhibitors: Synthetic lethality in the clinic

3. Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach

4. The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

5. Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between antipsychotics and pulmonary embolism: a pharmacovigilance analysis;Expert Opinion on Drug Safety;2024-08-27